These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 23398869

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
    Frei CR, Attridge RT, Mortensen EM, Restrepo MI, Yu Y, Oramasionwu CU, Ruiz JL, Burgess DS.
    Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. How Antibiotics Should be Prescribed to Hospitalized Elderly Patients with Community-Acquired Pneumonia.
    Arnold FW.
    Drugs Aging; 2017 Jan; 34(1):13-20. PubMed ID: 27928779
    [Abstract] [Full Text] [Related]

  • 26. In non-ICU suspected CAP, β-lactam was noninferior to β-lactam-macrolide or fluoroquinolone for 90-d mortality.
    Fekete T.
    Ann Intern Med; 2015 Sep 15; 163(6):JC5. PubMed ID: 26370032
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The controversy of combination vs monotherapy in the treatment of hospitalized community-acquired pneumonia.
    Weiss K, Tillotson GS.
    Chest; 2005 Aug 15; 128(2):940-6. PubMed ID: 16100190
    [Abstract] [Full Text] [Related]

  • 31. Cost-effectiveness of antibiotic treatment strategies for community-acquired pneumonia: results from a cluster randomized cross-over trial.
    van Werkhoven CH, Postma DF, Mangen MJ, Oosterheert JJ, Bonten MJ, CAP-START study group.
    BMC Infect Dis; 2017 Jan 10; 17(1):52. PubMed ID: 28068956
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Clinical failure with and without empiric atypical bacteria coverage in hospitalized adults with community-acquired pneumonia: a systematic review and meta-analysis.
    Eljaaly K, Alshehri S, Aljabri A, Abraham I, Al Mohajer M, Kalil AC, Nix DE.
    BMC Infect Dis; 2017 Jun 02; 17(1):385. PubMed ID: 28576117
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Antibiotic treatment of community acquired pneumonia varies widely across Germany.
    Kohlhammer Y, Raspe H, Marre R, Suttorp N, Welte T, Schäfer T, CAPNETZ study group.
    J Infect; 2007 May 02; 54(5):446-53. PubMed ID: 17007933
    [Abstract] [Full Text] [Related]

  • 37. Initial antibiotic selection and patient outcomes: observations from the National Pneumonia Project.
    Bratzler DW, Ma A, Nsa W.
    Clin Infect Dis; 2008 Dec 01; 47 Suppl 3():S193-201. PubMed ID: 18986289
    [Abstract] [Full Text] [Related]

  • 38. Coverage of atypical pathogens for hospitalised patients with community-acquired pneumonia is not guided by clinical parameters.
    Piso RJ, Arnold C, Bassetti S.
    Swiss Med Wkly; 2013 Dec 01; 143():w13870. PubMed ID: 24089030
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.